GSE203329 HCC knockout 0 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE203329_HCC knockout_0_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE203329_HCC knockout_0_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE203329_HCC knockout_0_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE203329_HCC knockout_0_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

non-coding RNA activated by DNA damage

Gene

TALAM1 transcript, MALAT1 antisense RNA

Gene

long intergenic non-protein coding RNA 641

Gene

TPTE pseudogene 1

Gene

mir-99a-let-7c cluster host gene

Gene

FTX transcript, XIST regulator

Gene

MIR9-2 host gene

Gene

ankyrin repeat domain 36B pseudogene 2

Gene

long intergenic non-protein coding RNA 891

Gene

long intergenic non-protein coding RNA 923

  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    TALAM1 transcript, MALAT1 antisense RNA


  • Gene

    long intergenic non-protein coding RNA 641


  • Gene

    TPTE pseudogene 1


  • Gene

    mir-99a-let-7c cluster host gene


  • Gene

    FTX transcript, XIST regulator



  • Gene

    ankyrin repeat domain 36B pseudogene 2


  • Gene

    long intergenic non-protein coding RNA 891


  • Gene

    long intergenic non-protein coding RNA 923

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.